R. Ramelmeier
Chief Tech/Sci/R&D Officer presso ADVERUM BIOTECHNOLOGIES, INC.
Patrimonio netto: 59 014 $ in data 31/03/2024
Profilo
R.
Andrew Ramelmeier is currently the Chief Technology Officer at Adverum Biotechnologies, Inc. He previously held positions as the Executive Director-Pharmaceutical Development at Centocor, Inc. from 2001 to 2005, Vice President-Process Sciences at Johnson & Johnson, VP-Manufacturing, Process Sciences & Facilities at BioMarin Pharmaceutical, Inc. from 2006 to 2014, Senior Vice President-Technical Operations at Portola Pharmaceuticals LLC from 2014 to 2017, and Chief Manufacturing & Quality Officer, Senior VP at Sangamo Therapeutics, Inc. from 2018 to 2023.
He obtained his undergraduate degree from The Johns Hopkins University in 1984 and his doctorate degree from the University of California, Berkeley in 1989.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 25/05/2023 | 88 080 ( 0.04% ) | 59 014 $ | 31/03/2024 |
Posizioni attive di R. Ramelmeier
| Società | Posizione | Inizio |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Chief Tech/Sci/R&D Officer | 21/08/2023 |
Precedenti posizioni note di R. Ramelmeier
| Società | Posizione | Fine |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 10/07/2023 |
| PORTOLA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2017 |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/01/2014 |
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Corporate Officer/Principal | 01/01/2005 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
Formazione di R. Ramelmeier
| The Johns Hopkins University | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- R. Ramelmeier
